Delivery Order SPE2DB24D2013-SPE2DB25FCHJX
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,054.20 Firm Fixed Price delivery order is for the supply of a specific pharmaceutical product, VIMPAT 200 MG TABLET 60S. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,854.18 firm fixed-price delivery order is for the supply of VIMPAT 150 MG Tablets, with a period of performance through January 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $1,936.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIMPAT 200 MG TABLET 60S, a prescription medication, to support military healthcare programs. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,353.53 firm-fixed-price delivery order is for the supply of VIMPAT 200 mg tablets, with a period of performance through May 31, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,253.92 firm fixed-price delivery order is for the supply of VIMPAT 200 MG TABLET 60S, a specialty pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,595.01 firm fixed-price delivery order is for the supply of VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for $1,313.04 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed-price delivery order for the pharmaceutical product VIMPAT 100 MG TABLET UD 60S, with a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and has no set-aside designation. This award is part of a larger indefinite delivery contract (IDC) valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,258.70 firm fixed-price delivery order is for the supply of VIMPAT 200 MG tablets, a prescription medication used to treat epilepsy. The contract has a completion date of July 7, 2022 and was awarded on July 6, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DX15D3504|SPE2DX25F01Z5, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,074.84 firm fixed-price delivery order is for the supply of VIMPAT 200 MG TABLET 60S. This contract is not designated as a set-aside and is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $3,592.94, is for the delivery of 60 count tablets of the pharmaceutical product VIMPAT 200 mg. This is a firm fixed price delivery order contract with a completion date of June 28, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major...